Attitudes, knowledge and expectations of patients with postmenopausal osteoporosis in Spain;Actitudes, conocimiento y expectativas de las pacientes con osteoporosis posmenopáusica en España

Progresos de Obstetricia y Ginecologia

Volumn 52, Issue 10, 2009, Pages 562-571

  Sánchez Borrego, Rafael ^a   Palacios, Santiago ^b   Neyro, José Luis ^c   Quereda, Francisco ^d   Vázquez, Francisco ^e   Pérez, Maite ^f  

^a Diatros   (Spain)

^b Instituto Palacios de Salud Y Medicina de la Mujer   (Spain)

^c HOSPITAL DE CRUCES   (Spain)

^d HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^e Centro Ginecológico CEOGA Lugo España   (Spain)

^f Laboratorios Almirall SA Barcelona España ^*  (Spain)

Author keywords

Attitudes; Epidemiological study; Knowledge; Patient profile; Postmenopausal osteoporosis

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; ATTITUDE TO HEALTH; DIET; DRINKING BEHAVIOR; FAMILY HISTORY; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; POSTMENOPAUSE OSTEOPOROSIS; QUESTIONNAIRE; SMOKING; SPAIN;

EID: 70350728325     PISSN: 03045013     EISSN: 15781453     Source Type: Journal    
DOI: 10.1016/S0304-5013(09)72622-6     Document Type: Article

References (25)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 285 (2001) 785-795
2. Seeman E., and Delmas P.D. Bone quality-the material and structural basis of bone strength and fragility. N Engl J Med 354 (2006) 2250
3. Kanis J.A., Oden A., Johnell O., Jonsson B., de Laet C., and Dawson A. The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12 (2001) 417
4. National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis (2003), National Osteoporosis Foundation, Washington
5. World Health Organization. Osteoporosis: both health organizations and individuals must act now to avoid an impending epidemic. Press release WHO/58 11 October 1999. [Accedido 4 Nov 2007]. Disponible en: www.who.int/inf-pr-1999/en/pr99-58.htm
6. Siris E.S., Chen Y.T., Abbott T.A., Barrett-Connor E., Miller P.D., Wehren L.E., and Berger M.L. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164 (2004) 1108-1112
7. Díaz-Curiel M., García J.J., Carrasco J.L., Honorato J., Pérez Cano R., Rapado A., et al. Prevalencia de osteoporosis determinada por densitometría en la población femenina española. Med Clin (Barc) 116 (2001) 86-88
8. Díez A., Puig J., Nogués X., Knobel H., Mínguez S., Supervía A., et al. Cribado de riesgo óseo mediante factores clínicos en mujeres tras menopausia fisiológica. Med Clin (Barc) 110 (1998) 121-124
9. Ferrer J., Neyro J.L., and Estévez A. Identification of risk factors for prevention and early diagnosis of a-symptomatic postmenopausal women. Maturitas 52 Suppl 1 (2005) S7-S22
10. Kanis J.A., Borgstrom F., De Laet C., Johansson H., Johnell O., Jonsson B., et al. Assessment of fracture risk. Osteoporos Int 16 (2005) 581
11. Palacios S., Sánchez-Borrego R., and Forteza A. The importance of preventive health care in post-menopausal women. Maturitas 52 Suppl 1 (2005) S53-60
12. Boonen S., Laan R.F., Barton I.P., and Watts N.B. Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies. Osteoporosis Int 16 (2005) 1291-1298
13. North American Menopause Society. Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society. Menopause 13 (2006) 340-367
14. International Guidelines for Ethical Review of Epidemiological Studies (Council for the International Organizations of Medical Sciences -CIOMS-). Ginebra, 1991.
15. Tormo M.J., Dal-Ré R., and Pérez G. Ética e investigación epidemiológica: principios, aplicaciones y casos prácticos (1998), Sociedad Española de Epidemiología, Barcelona
16. Haynes R.B., Taylor W.D., and Sackett D.L. Compliance in Health Care (1979), The Johns Hopkins University Press, Baltimore
17. EMEA, Committee for Medicinal Products for Human Use. Guideline on the evaluation of medicinal products in the treatment of primary osteoporosis. Adopted November 16, 2006. [Accedido Nov 2007]. Disponible en: www.emea.europa.eu
18. Delaney M.F. Strategies for the prevention and treatment of osteoporosis during early postmenopause. Am J Obstet Gynecol 194 2 Suppl (2006) S12-S23
19. Gold D.T. Medication adherence: a challenge for patients with postmenopausal osteoporosis and other chronic illnesses. J Manag Care Pharm 12 6 Suppl A (2006) S20-S25
20. Brookhart M.A., Avorn J., Katz J.N., Finkelstein J.S., Arnold M., Polinski J.M., et al. Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance. Am J Med 120 (2007) 251-256
21. Weycker D., Macarios D., Edelsberg J., and Oster G. Compliance with osteoporosis drug therapy and risk of fracture. Osteoporos Int 18 (2007) 271-277
22. Kutsal Y.G., Atalay A., Arslan S., Basaran A., Cantürk F., Cindas A., et al. Awareness of osteoporotic patients. Osteoporosis Int 16 (2005) 128-133
23. Vélez M.C., Caballero-Uribe C.V., Tuesca-Molina R., Ochoa V., Hernández A., and Forero L. Conocimientos, actitudes y estilos de vida frente a la osteoporosis en una ciudad del Caribe colombiano. Salud Uninorte 22 (2006) 73-83
24. Magnus J.H., Joakimsen R.M., Berntsen G.K., Tollan A., and Sogaard A.J. What do Norwegian women and men know about osteoporosis?. Osteoporos Int 6 (1996) 31-36
25. Blouin J., Dragomir A., Moride Y., Ste-Marie L.G., Fernandes J.C., and Perreault S. Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women. Br J Clin Pharmacol 66 (2008) 117-127